Eton Pharmaceuticals, Inc. Repayments of Debt
Eton Pharmaceuticals, Inc. (ETON) reported Repayments of Debt of $1.16 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2024-03-14
- Eton Pharmaceuticals, Inc. repayments of debt for fiscal 2023 was $1.16M, a 200.00% increase from fiscal 2022.
- Eton Pharmaceuticals, Inc. repayments of debt for fiscal 2022 was $385.00K, a 156.67% increase from fiscal 2021.
- Eton Pharmaceuticals, Inc. repayments of debt for fiscal 2021 was $150.00K.
| Period end | Repayments of Debt 12 month |
|---|---|
| 2023-12-31 | $1.16M 10-K · filed 2024-03-14 |
| 2022-12-31 | $385.00K 10-K · filed 2024-03-14 |
| 2021-12-31 | $150.00K 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |